Product image of Minisiston 20 Fem (Ethinylestradiol, Levonorgestrel) supplied by GNH India

Minisiston 20 Fem

Active Ingredient:
Ethinylestradiol, Levonorgestrel
Origin:
EU

Minisiston 20 Fem (Ethinylestradiol, Levonorgestrel)

Ethinylestradiol and Levonorgestrel, the active ingredients in Minisiston 20 Fem, are a combined oral contraceptive presented as Ethinylestradiol 20 µg / Levonorgestrel 100 µg tablets for oral use. It is prescribed to prevent pregnancy in women of reproductive age.
GNH India supplies Minisiston 20 Fem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Jenapharm Gmbh & Co Kg

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Minisiston 20 Fem, a combined oral contraceptive, works within the hormonal reproductive pathway to prevent unintended pregnancy.

  • Prevention of pregnancy: Provides reliable contraceptive protection when taken as directed.
  • Regulation of menstrual cycles: Helps achieve more predictable cycle timing and flow.
  • Treatment of moderate acne: Reduces androgen‑driven skin lesions in some women.

How It Works

  • Ethinylestradiol and levonorgestrel act on the hypothalamic‑pituitary‑ovarian axis. Ethinylestradiol suppresses follicle‑stimulating hormone release, while levonorgestrel inhibits luteinizing hormone surge, preventing ovulation. The progestogenic component also thickens cervical mucus and induces endometrial changes that reduce the likelihood of implantation.

Side Effects

Common Side Effects

  • Nausea: Mild to moderate stomach upset.
  • Headache: Tension‑type or migraine‑like pain.
  • Breast tenderness: Temporary swelling or discomfort.
  • Spotting between periods: Light bleeding episodes.
  • Weight fluctuations: Minor changes in fluid retention.
  • Mood changes: Irritability or mild mood swings.

Serious or Rare Side Effects

  • Deep vein thrombosis: Blood clot formation in legs.
  • Pulmonary embolism: Blockage of lung arteries.
  • Stroke: Cerebrovascular accident risk.
  • Severe allergic reaction: Rash, swelling, or breathing difficulty.
  • Liver dysfunction: Jaundice or abnormal liver enzymes.
  • Hypertension: Significant rise in blood pressure.

Precautions & Warnings

Before using Minisiston 20 Fem, consider the following precautions:

  • Smoking: Avoid if over 35 years old and a smoker due to increased cardiovascular risk.
  • History of clotting disorders: Discuss with a healthcare professional.
  • Migraine with aura: Use alternative contraception if present.
  • Liver disease: Assess liver function prior to initiation.
  • Breast cancer history: Contraindicated in active or past cases.
  • Store at ambient temperature: Keep below 25°C, retain in original packaging, protect from moisture.

Avoid Interactions

Minisiston 20 Fem may interact with several medicines.

Major Interactions (Avoid)

  • Antiepileptic enzymes inducers (e.g., carbamazepine, phenytoin): Reduce contraceptive efficacy.
  • Rifampin and other potent inducers: May lead to contraceptive failure.
  • Certain HIV protease inhibitors: Can increase hormone levels and risk of side effects.

Moderate Interactions (Monitor Closely)

  • Antifungal azoles (e.g., ketoconazole): May increase hormone concentrations.
  • St. John’s Wort: May lower effectiveness of the pill.
  • Antibiotics (e.g., tetracycline): Generally minimal effect but monitor for breakthrough bleeding.

Frequently Asked Questions

Minisiston 20 Fem is a combined oral contraceptive tablet containing ethinylestradiol and levonorgestrel. It is prescribed to prevent pregnancy by inhibiting ovulation, thickening cervical mucus, and altering the uterine lining to reduce the chance of implantation.

Ethinylestradiol is a synthetic estrogen that suppresses the release of follicle‑stimulating hormone from the pituitary gland. This suppression helps prevent the development of a dominant follicle, thereby reducing the likelihood of ovulation when used with levonorgestrel.

The dosing regimen for Minisiston 20 Fem is determined by the prescribing clinician. Typically, the tablet is taken once daily at the same time each day, but the exact schedule should follow the healthcare provider’s instructions.

Minisiston 20 Fem is not intended for use during pregnancy and should be discontinued if pregnancy occurs. Limited data are available for breastfeeding; women should discuss risks and benefits with their healthcare professional before using the product while nursing.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Minisiston 20 Fem contains a low‑dose estrogen (20 µg) combined with 100 µg levonorgestrel, offering effective contraception with a favorable side‑effect profile. Compared with higher‑dose formulations, it may reduce estrogen‑related adverse events while maintaining comparable contraceptive efficacy.

Store Minisiston 20 Fem at ambient temperature below 25 °C. Keep the tablets in the original blister pack, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

The tablet is taken orally, usually with water, once each day at the same time. It should be swallowed whole and not chewed or broken. Consistency in timing helps maintain steady hormone levels for optimal contraceptive effect.

Serious risks include venous thromboembolism, pulmonary embolism, stroke, and myocardial infarction, especially in women who smoke, are over 35 years old, or have a history of clotting disorders. Prompt medical attention is required if symptoms such as severe leg pain, chest pain, or sudden neurological changes occur.

Women with a known hypersensitivity to either component, active or past breast cancer, uncontrolled hypertension, a history of thromboembolic disease, or those who are pregnant should avoid using Minisiston 20 Fem. Consultation with a healthcare professional is essential to assess suitability.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ethinylestradiol, Levonorgestrel

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT